Rights and permissions
About this article
Cite this article
Natalizumab maintains response in Crohn's disease. Inpharma Wkly. 1458, 8 (2004). https://doi.org/10.2165/00128413-200414580-00015
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414580-00015